flowbone SA

flowbone SA is a Swiss private medtech company focused on developing an injectable biomaterial for the augmentation and strengthening of fragile bones. This innovative technology targets conditions like osteoporosis-related fractures, particularly in high-risk areas such as the spine and hips. The biomaterial is designed to enhance bone repair and prevent fragility fractures without disrupting bone mechanics or blood flow. The company’s product is based on over six years of research from the École Polytechnique Fédérale de Lausanne (EPFL) and is currently in the pre-clinical phase, preparing for clinical trials. flowbone SA operates in the medical technology sector, concentrating on orthopaedic and rehabilitation solutions, as well as regenerative therapies. Their business model is B2B, catering to healthcare providers and institutions involved in treating bone fragility and fractures. Based in Renens, Switzerland, flowbone SA boasts a team of experts in medical device innovation and clinical application.

• Employees 9